NCM
SCLN
Nantahala Capital Management’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-1,891,328
| Closed | -$18.5M | – | 64 |
|
|
2017
Q1 | $18.5M | Sell |
1,891,328
-277,715
| -13% | -$2.72M | 2.06% | 13 |
|
|
2016
Q4 | $23.4M | Buy |
2,169,043
+399,485
| +23% | +$4.31M | 2.43% | 8 |
|
|
2016
Q3 | $18.1M | Hold |
1,769,558
| – | – | 2.19% | 10 |
|
|
2016
Q2 | $23.1M | Sell |
1,769,558
-255,592
| -13% | -$3.34M | 2.51% | 8 |
|
|
2016
Q1 | $22.3M | Buy |
2,025,150
+1,453,263
| +254% | +$16M | 2.29% | 6 |
|
|
2015
Q4 | $5.26M | Buy |
571,887
+401,669
| +236% | +$3.7M | 0.69% | 34 |
|
|
2015
Q3 | $1.18M | Sell |
170,218
-893,302
| -84% | -$6.2M | 0.16% | 53 |
|
|
2015
Q2 | $10.4M | Sell |
1,063,520
-459,105
| -30% | -$4.51M | 1.53% | 16 |
|
|
2015
Q1 | $13.5M | Buy |
1,522,625
+133,100
| +10% | +$1.18M | 2.24% | 5 |
|
|
2014
Q4 | $12.2M | Sell |
1,389,525
-480,842
| -26% | -$4.21M | 1.71% | 6 |
|
|
2014
Q3 | $12.9M | Buy |
1,870,367
+30,739
| +2% | +$212K | 1.58% | 7 |
|
|
2014
Q2 | $9.68M | Buy |
1,839,628
+77,577
| +4% | +$408K | 1.42% | 11 |
|
|
2014
Q1 | $8.02M | Buy |
1,762,051
+226,850
| +15% | +$1.03M | 1.29% | 11 |
|
|
2013
Q4 | $7.74M | Buy |
1,535,201
+588,253
| +62% | +$2.96M | 1.25% | 14 |
|
|
2013
Q3 | $4.8M | Buy |
946,948
+18,739
| +2% | +$95K | 1.07% | 23 |
|
|
2013
Q2 | $4.6M | Buy |
+928,209
| New | +$4.6M | 1.07% | 24 |
|